(Middle) Upon reaching the tumor site, these nanocarriers exert their therapeutic effects through three primary mechanisms (1): Macrophage Reprogramming, where the delivery of immunomodulators (e.g., TLR agonists) converts tumor-promoting, anti-inflammatory M2 macrophages into tumor-suppressive, pro-inflammatory M1 macrophages
Anti-inflammatory effect of glucagon like peptide-1 receptor agonist, exendin-4, through modulation of IB1/JIP1 expression and JNK signaling in stroke
Ard J, Fitch A, Fruh S, Herman L
We are also providing Medicine Drop Shipping Service
In clinical research, these pathways have been associated with reduced appetite, improved control of food intake, slower stomach emptying (which can increase fullness), and better blood sugar regulation